Fasikl

Fasikl Inc. is a privately held company based in the United States. Founded in 2019 as a spin-off from the University of Minnesota, Fasikl is a small company with 5 employees. Fasikl develops AI-supported neural technologies specializing in neuro-AI. Their core products utilize proprietary technology to capture neural signals from nerves, which are then used to inform AI-driven therapies. Fasikl's target customers are likely individuals and institutions within the healthcare sector seeking innovative neurotherapy solutions. Fasikl distinguishes itself through its proprietary technology for acquiring neural signals and its dedication to pioneering AI-driven therapies. The company's mission emphasizes making a significant positive impact on patient well-being through advancements in neurotherapies. Interested parties can learn more about Fasikl and its products by visiting their website at fasikl.com.